Salbutamol or mist in acute bronchiolitis . 
<br>
<br> BACKGROUND The role of bronchodilators in the treatment of bronchiolitis remains controversial . 
<br> METHODS A double - blind , placebo controlled trial was performed to evaluate the clinical response to nebulized salbutamol . One hundred and fifty - six infants aged between 7 weeks and 24 months who had had an <font color="blue">episode_1</font> <font color="blue">of_1</font> <font color="blue">wheezing_1</font> <font color="blue">and_1</font> <font color="blue">other_1</font> <font color="blue">signs_1</font> <font color="blue">and_1</font> <font color="blue">symptoms_1</font> <font color="blue">of_1</font> <font color="blue">bronchiolitis_1</font> were randomized to three groups as follows : ( i ) nebulized salbutamol was administered to 52 patients in group I at a dose of 0.15 mg / kg in 2 mL saline ; ( ii ) saline was nebulized to 52 patients in group II and ( iii ) in group III 52 patients received mist in a tent . All three groups were <font color="blue">administered_1</font> <font color="blue">oxygen_1</font> during the procedures . Treatment was repeated with the same agent after 30 min if the <font color="blue">respiratory_1</font> <font color="blue">score_1</font> <font color="blue">was_1</font> <font color="blue">5_1</font> <font color="blue">or_1</font> <font color="blue">more_1</font> <font color="blue">._1</font> <font color="blue">Respiratory_4</font> <font color="blue">rate_4</font> <font color="blue">,_4</font> <font color="blue">heart_4</font> <font color="blue">rate_4</font> <font color="blue">,_4</font> <font color="blue">oxygen_4</font> <font color="blue">saturation_4</font> <font color="blue">and_4</font> <font color="blue">presence_4</font> <font color="blue">of_4</font> <font color="blue">cyanosis_4</font> <font color="blue">,_4</font> <font color="blue">wheezing_4</font> <font color="blue">,_4</font> <font color="blue">retractions_4</font> <font color="blue">were_1</font> <font color="blue">recorded_1</font> before and after each treatment . 
<br> RESULTS The <font color="blue">decrease_1</font> <font color="blue">in_1</font> <font color="blue">the_1</font> <font color="blue">respiratory_4</font> <font color="blue">score_4</font> was 5.2 + /- 1.8 , 0.82 + /- 2.4 and 1.7 + /- 1.3 in group I , II and III , respectively . The <font color="blue">decrease_1</font> in group I was significantly higher than in the other groups . <font color="blue">Heart_4</font> <font color="blue">rate_4</font> <font color="blue">was_1</font> <font color="blue">similar_1</font> between groups . <font color="blue">Oxygen_4</font> <font color="blue">saturation_4</font> <font color="blue">decreased_2</font> in group I without reaching statistical significance . 
<br> CONCLUSIONS <font color="blue">Salbutamol_1</font> <font color="blue">was_1</font> <font color="blue">shown_1</font> <font color="blue">to_1</font> <font color="blue">be_1</font> <font color="blue">effective_3</font> <font color="blue">and_3</font> <font color="blue">safe_3</font> <font color="blue">in_1</font> <font color="blue">the_1</font> <font color="blue">treatment_1</font> <font color="blue">of_1</font> <font color="blue">acute_1</font> <font color="blue">bronchiolitis_1</font> <font color="blue">._1</font>